fashion -WSS

fashion

author：comprehensive 2025-09-06 02:06:11 - browse：9

Immunofluorescence image shows CD4+ (green) and CD8+ (yellow) T cells in the microenvironment of a head and neck squamous cell carcinoma. — This immunofluorescence image shows T cells (in green and yellow) in the microenvironment of a head and neck squamous cell carcinoma. Allen Lab/NCI/NIH

Merus said Tuesday that the combination of its experimental drug petosemtamab with the checkpoint inhibitor Keytruda shrank tumors in 62% of patients with head and neck cancer, according to an interim analysis of an ongoing mid-stage clinical trial.

The new efficacy results, derived from a larger number of patients, look similar to an initial disclosure made last week that triggered a 36% increase in Merus’ stock price.

But the Dutch drugmaker on Tuesday withheld additional information from the study related to the safety and durability of petosemtamab’s tumor responses, pending presentation at the annual meeting of the American Society of Clinical Oncology on June 3.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Why Congress must ban federal programs from using QALYs

hotspot

Wikipedia

WSS

EF3 tornado rips through North Carolina amid extreme weather nationwide

Bird flu in milk supply is likely coming from asymptomatic cows

Vir antibody drug aimed at influenza A fails in clinical trial

Getting Alzheimer's drug Leqembi to patients can be a challenge

Why rehabilitation engineers need to center patients in their research

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

hotspot

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

knowledge

Heart attack and stroke risk calculators need revising

Jury awards Florida girl burned by McDonald's Chicken McNugget $800,000 in damages

Jerome Adams on the need for new antivirals for Covid

Health care needs a new profession: neuroimaging counseling

Jerome Adams on the need for new antivirals for Covid

Awakening the world to the whoosh: A patient's crusade

Trump demands the U.S. pay no more for drugs than other countries … again

Senate committee advances SCOTUS ethics bill after alleged justice misconduct

Medical leaders decry Supreme Court decision on affirmative action

Driven by the pandemic, applicants flood public health schools

focus

I learned firsthand about improving diversity in clinical trials

Driven by the pandemic, applicants flood public health schools

Awakening the world to the whoosh: A patient's crusade

Key Senate committee drafts bipartisan bill to stem drug shortages

Orangutan used medicinal plant to treat wound, first time ever seen

Jury awards Florida girl burned by McDonald's Chicken McNugget $800,000 in damages

entertainment

hotspot

Wikipedia

explore